Burning Rock Biotech (BNR) Return on Sales (2019 - 2025)

Burning Rock Biotech's Return on Sales history runs 7 years deep, the most recent figure standing at 0.0% for Q4 2025.

• In Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (up 1.0% YoY), while the FY2025 annual figure was 0.0%, up 1.0% from the prior year.
• Return on Sales was 0.0% for Q4 2025 at Burning Rock Biotech, up from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q2 2025 to a low of 0.02% in Q2 2022.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.01% in 2023.
• The sharpest annual moves came in 2021 and 2023: Return on Sales slipped 1 bps in 2021, then gained 1 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.02% in 2021, then climbed by 13 bps to 0.01% in 2022, then gained by 11 bps to 0.01% in 2023, then jumped by 58 bps to 0.01% in 2024, then jumped by 81 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.